tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

MIRM Stock Latest News

Mirum Files Patent Suits to Block Livmarli Generics
Company AnnouncementsMirum Files Patent Suits to Block Livmarli Generics
19d ago
8K
MIRM
Mirum Pharmaceuticals Raises Capital via Private Placement
PremiumCompany Announcements
Mirum Pharmaceuticals Raises Capital via Private Placement
19d ago
8K
MIRM
Mirum Pharmaceuticals price target raised to $140 from $95 at Citizens
PremiumThe Fly
Mirum Pharmaceuticals price target raised to $140 from $95 at Citizens
19d ago
MIRM
Mirum Pharmaceuticals price target raised to $100 from $90 at Leerink
PremiumThe Fly
Mirum Pharmaceuticals price target raised to $100 from $90 at Leerink
28d ago
MIRM
Mirum Pharmaceuticals price target raised to $95 from $81 at Morgan Stanley
PremiumThe Fly
Mirum Pharmaceuticals price target raised to $95 from $81 at Morgan Stanley
29d ago
MIRM
Mirum Pharmaceuticals price target raised to $88 from $80 at Baird
PremiumThe FlyMirum Pharmaceuticals price target raised to $88 from $80 at Baird
29d ago
MIRM
Strategic Acquisition Positions Mirum Pharmaceuticals for Leadership in Rare Liver Disease Market
Premium
Ratings
Strategic Acquisition Positions Mirum Pharmaceuticals for Leadership in Rare Liver Disease Market
29d ago
MIRM
Strategic Acquisition and Market Potential Drive Buy Rating for Mirum Pharmaceuticals
Premium
Ratings
Strategic Acquisition and Market Potential Drive Buy Rating for Mirum Pharmaceuticals
30d ago
MIRM
Mirum Pharmaceuticals price target raised to $94 from $89 at Evercore ISI
PremiumThe Fly
Mirum Pharmaceuticals price target raised to $94 from $89 at Evercore ISI
30d ago
MIRM
Mirum’s deal for Bluejay a positive readthrough to Vir, says Needham
PremiumThe Fly
Mirum’s deal for Bluejay a positive readthrough to Vir, says Needham
1M ago
VIR
GILD
Mirum Pharmaceuticals price target raised to $130 from $95 at Cantor Fitzgerald
PremiumThe Fly
Mirum Pharmaceuticals price target raised to $130 from $95 at Cantor Fitzgerald
1M ago
MIRM
Mirum Pharmaceuticals Announces Merger with Bluejay Therapeutics
PremiumCompany Announcements
Mirum Pharmaceuticals Announces Merger with Bluejay Therapeutics
1M ago
8K
MIRM
Mirum Pharmaceuticals to acquire Bluejay Therapeutics in cash, stock transaction
PremiumThe FlyMirum Pharmaceuticals to acquire Bluejay Therapeutics in cash, stock transaction
1M ago
MIRM
Mirum Pharmaceuticals enrolls first patient in Phase 2 BLOOM study of MRM-3379
Premium
The Fly
Mirum Pharmaceuticals enrolls first patient in Phase 2 BLOOM study of MRM-3379
1M ago
MIRM
Mirum Pharmaceuticals: Strategic Positioning and Strong Defense Justify Buy Rating
Premium
Ratings
Mirum Pharmaceuticals: Strategic Positioning and Strong Defense Justify Buy Rating
2M ago
MIRM
Mirum Pharmaceuticals Faces Patent Challenge from Sandoz
PremiumCompany Announcements
Mirum Pharmaceuticals Faces Patent Challenge from Sandoz
2M ago
8K
MIRM
Mirum Pharmaceuticals Reports Robust Q3 Growth and Milestones
PremiumCompany Announcements
Mirum Pharmaceuticals Reports Robust Q3 Growth and Milestones
2M ago
MIRM
Mirum Pharmaceuticals price target raised to $95 from $85 at Cantor Fitzgerald
PremiumThe Fly
Mirum Pharmaceuticals price target raised to $95 from $85 at Cantor Fitzgerald
2M ago
MIRM
Mirum Pharmaceuticals price target raised to $81 from $80 at H.C. Wainwright
PremiumThe Fly
Mirum Pharmaceuticals price target raised to $81 from $80 at H.C. Wainwright
2M ago
MIRM
Mirum Pharmaceuticals price target raised to $95 from $81 at Citizens JMP
PremiumThe FlyMirum Pharmaceuticals price target raised to $95 from $81 at Citizens JMP
2M ago
MIRM
Mirum Pharmaceuticals Reports Strong Q3 2025 Growth
Premium
Company Announcements
Mirum Pharmaceuticals Reports Strong Q3 2025 Growth
2M ago
MIRM
Mirum Pharmaceuticals: Strong Q3 Performance and Promising Pipeline Drive Buy Rating
Premium
Ratings
Mirum Pharmaceuticals: Strong Q3 Performance and Promising Pipeline Drive Buy Rating
2M ago
MIRM

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >